I think Trimesta uncertainty is dragging SYN down like a lead weight. If they can partner it, we'd finally start seeing positive market reaction for other parts of the pipeline. Trimesta has been killing them since this team took over. Legacy drug from hell.
News 
Market Data 
Discover 
